CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čes. Gynek. 69, 2004, č. 5 s. 366-371
 
Adjuvant Radiotherapy in the Therapy of Uterus Body Cancer in the First Clinical Stage 
Horová H.1, Růžičková J.1, Ježková B.1, Horová I.2, Budíková M.2, Dörr A.3 

1Oddělení radiační onkologie, Masarykův onkologický ústav, Brno, vedoucí oddělení doc. MUDr. P. Šlampa, CSc. 2Katedra aplikované matematiky, Přírodovědecká fakulta MU, Brno, vedoucí katedry prof. RNDr. I. Horová, CSc. 3Oddělení gynekologické onkologie, Masarykův onkologický ústav, Brno, vedoucí oddělení MUDr. A. Dörr
 


Summary:

       Objective: The aim of our study was to fi nd the infl uence of the postoperative radiotherapy on local control and overal survival in patients with carcinoma of the uterus. Endometrial carcinoma is the most frequent gynecologic malignity. Surgery, radiotherapy, chemotherapy and hormonal therapy are used in the treatment of this disease. The optimal cure strategy has not been established yet. Design: retrospective study. Setting: Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno. Methods: We followed up 246 patients with the diagnosis of endometrial carcinoma. All patients were in clinical stage 1. Median of the age was 60 years. Every patient underwent radical hysterectomy and adnexectomy. Most of them had adjuvant radiotherapy. Combined radiotherapy was used (external beam radiotherapy and brachyradiotherapy). Some of patients underwent only external beam radiotherapy, other had only brachytherapy. We used Kaplan-Meier survival function and methods of Statistica. Results: The median of the follow up was 8.3 years. Local recurrence was proved in 16 cases. The time to the local relapse was 3.2 years. Dissemination occurred in 12 patients. The time to the progression was 5.9 years. Five-year DFS was 80.9%, fi ve-year overal survival was 82.9%. Patients, who had risk factors, were proved to suffer from worse overal survival. The adjuvant radiotherapy improved the local, and the distant control in the group of patients with risk factors. Conclusion: The infl uence of the radiotherapy on the local control was proved in many studies, the infl uence on the overal survival was not statistically signifi cant. Temporally there is the option not to apply adjuvant radiotherapy. Our study shows the important benefi t of the adjuvant treatment in cases of endometrial carcinoma and risk factors.

        Key words: endometrial carcinoma, adjuvant radiotherapy
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER